Company Overview and News

34
ShareRoot well positioned as key EU data privacy legislation goes into effect

2018-05-25 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) welcomes the European Union’s General Data Protection Regulation (GDPR) which goes into effect today.
FB SRO

0
"There's no doubt that ShareRoot is positioned in the right place at the right time"

2018-04-26 proactiveinvestors.com.au
ShareRoot (ASX:SRO) CEO Noah Abelson-Gertler explains how recent changes to the board represent a key transition towards profitability for the company’s User Generated Content (UGC) Legal Rights Management platform.
SRO

0
ShareRoot finalising shift towards profitability for UGC platform

2018-04-24 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) will be shifting into profitability after the completion of new features for its user-generated content (UGC) legal rights platform.
SRO

0
ShareRoot Ltd hires leader 'instrumental' in uncovering Cambridge Analytica and Facebook scandal

2018-04-18 proactiveinvestors.com.au
ShareRoot (ASX:SRO) CEO Noah Abelson-Gertler tells Proactive Investors the company has appointed Paul-Olivier Dehaye, a data and privacy expert, to join the advisory board.
SRO

1
ShareRoot appoints top customer data privacy experts as advisors

2018-04-12 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) has appointed Dr Paul-Olivier Dehaye and Jerome Groetenbriel, both co-founders of PersonalData.IO, experts in customer data collection, mining and protection as advisors to the company.
NYTAB SRO

0
ShareRoot locks in additional revenues by completing TSS acquisition

2018-04-09 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) has completed the acquisition of The Social Science (TSS), expanding the company’s product offering.
SRO

0
ShareRoot pitches MediaConsent solution to data privacy concerns for consumers and companies

2018-04-06 proactiveinvestors.com.au
Noah Abelson-Gertler, chief executive of ShareRoot Ltd (ASX:SRO), updates Proactive Investors ahead of presentations at the TechKnow Invest Roadshow in Sydney on April 10 and Melbourne on April 12.
SRO

34
ShareRoot to present why it can help companies like Facebook stop privacy infringements

2018-04-03 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) will present at the upcoming TechKnow Investors conference in Sydney and Melbourne on April 10 and 12 respectively.
FB SRO

12
Shareroot contract renewals provide predictable revenue as new products take shape

2018-03-22 proactiveinvestors.com.au
ShareRoot Limited (ASX:SRO) has strengthened its sales pipeline after securing four contract renewals, one of which is a high profile global retail chain.
COST SRO MCD

0
ShareRoot targeting multi-billion industry with roll-out of MediaConsent platform

2018-03-12 proactiveinvestors.com.au
ShareRoot Ltd (ASX:SRO) will look to complement its existing platform with the roll-out of the MediaConsent platform this quarter.
SAP SAPGF SRO DCC

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

20h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

20h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to ASX:SRO / SHAREROOT LTD on message board site Silicon Investor.

Crossroads - CRDS Seine River Resourses SRO.Vse
Our Town, USA/Concord Newsroom (OTUSA/CIGI) AA NEW ARCADIA RESOURCES OIL/GAS SEINE RIVER PROJECT.